• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Aristada Expansion Cancelled

What once was a promising company has turned to shit. Above poster is correct that the ship is taking on water. Amazing that a cEO as smart as Pops has let this happen. Too bad so sad
God, this is the truth. This company has hit the bottom. A year ago, I loved working here and now the culture sucks. I think Pops is a good CEO, if it was 2005. He did not change his way of thinking. Sad, so sad.